Concepedia

Publication | Closed Access

Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.

DOI

10

Citations

0

References

2013

Year

Hanzhi Cui, Guanghai Dai, Yan Shi, Li Chen
PubMed

Abstract

Sorafenib combined with TACE is a safe and effective treatment of advanced primary hepatocellular carcinoma.